Home :: Tag Archives: a company focused on the development of novel biologics for complex regeneration and disease reversion

Tag Archives: a company focused on the development of novel biologics for complex regeneration and disease reversion

Is death reversible?

We are repeatedly told through the medical establishment that brain death is “irreversible” and should be considered the end of the line. Or is it? Two biosciences companies are studying a clinical intervention in the state of death. Bioquark, a company focused on the development of novel biologics for complex regeneration and disease reversion, and Revita Life Sciences, a biotechnology ...

Read More »